Research graph
References from Cost-effectiveness of Fufang Huangbai fluid versus Suprasorb® A + Ag antimicrobial calcium alginate wound dressing for treating IWGDF/IDSA grade 1–2 diabetic foot ulcers. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical observation on treatment of diabetic foot ulcer of Wagner grade 1‒2 by compound huangbai liquid fomentation
2023 · External reference
Expert consensus on wound treatment of diabetic foot ulcer (2024)
2024 · External reference
Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update)
10.1002/dmrr.3654 · 2024 · External reference
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
10.1016/s0140-6736(23)01301-6 · 2023 · External reference
The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050
10.1186/s40779-025-00615-1 · 2025 · External reference
Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers
10.2337/dci22-0043 · 2023 · External reference
IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
10.1016/j.diabres.2021.109119 · 2022 · External reference
Chinese guideline on prevention and management of diabetic foot (2019 edition) (Ⅰ)
2019 · External reference
Health economics of diabetic foot ulcer and recent trends to accelerate treatment
10.1016/j.foot.2022.101909 · 2022 · External reference
IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023)
10.1002/dmrr.3687 · 2024 · External reference
Alginate/polycaprolactone composite fibers as multifunctional wound dressings
10.1016/j.carbpol.2022.119440 · 2022 · External reference
Research progress of Cortex Phellodendri in the chemical constituents and their pharmacological effects
2018 · External reference
Review of pharmacological actions of effective components of Phellodendron Chinense
2022 · External reference
Comparative analysis of active constituents of Forsythia suspensa and its antioxidative and antimicrobial properties
2023 · External reference
Research progress in the antibacterial effect of active ingredients of Lonicerae japonicae Flos
2023 · External reference
Research progress on antibacterial and antiviral effect and clinical application of dandelion
2022 · External reference
Mechanism of antimicrobial peptide scolopin 2-NH2 isolated from Scolopendra subspinipes mutilans
2018 · External reference
Comparison of clinical effect of Fufang Huangbai Ye and povidone-iodine in treatment of diabetic foot infection
2016 · External reference
Observation on the efficacy of compound Huangbai liquid solution applied externally to control the infection of multiple drug-resistant bacteria in diabetes foot
2023 · External reference
Efficacy of an externally applied agent, compound cortex phellodendri liquid, for the treatment of Wagner grade 2‒3 diabetic foot ulcers via combined wet compress therapy and dipping bath and its influence on serum inflammatory factors
2023 · External reference
Current trends in advanced alginate-based wound dressings for chronic wounds
10.3390/jpm11090890 · 2021 · External reference
Wet-spun bi-component alginate based hydrogel fibers: development and in-vitro evaluation as a potential moist wound care dressing
10.1016/j.ijbiomac.2020.12.088 · 2021 · External reference
Fabrication and characterization of silver nanowire-coated porous alginate wet-laid webs for wound dressing applications
10.1016/j.ijbiomac.2025.139770 · 2025 · External reference
The global burden of diabetes mellitus
2016 · External reference
Chinese guideline on prevention and management of diabetic foot (2019 edition) (Ⅲ)
2019 · External reference
Chinese time trade-off values for EQ-5D health states
10.1016/j.jval.2014.05.007 · 2014 · External reference
Pharmacoeconomic evaluation of pentoxifylline sustained release tablets in the treatment of diabetic foot
2022 · External reference
Research progress on drug resistance characteristics and treatment of pathogenic bacteria in patients with diabetic foot infection
2025 · External reference
Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: a systematic review
10.1371/journal.pone.0232395 · 2020 · External reference
Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments
10.1016/s1262-3636(07)70154-4 · 2004 · External reference
Probabilistic sensitivity analysis incorporating the bootstrap: an example comparing treatments for the eradication of Helicobacter pylori
10.1177/0272989x9901900314 · 1999 · External reference
Application of non-parametric bootstrap method in the evaluation of confidence intervals of cost-effectiveness
2010 · External reference
